NR1D1 and lung adenocarcinoma: Further investigation in cell lines showed that the downregulation of REV-ERBα promotes the migration and proliferation of lung adenocarcinoma cells and also leads to increased expression levels of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), indicating a potentially implicated molecular pathway [42].